Parumasivam, T <br/><br/>
In Vitro Evaluation of Inhalable Verapamil-Rifapentine Particles for Tuberculosis Therapy.  [electronic resource] 

 -  Molecular pharmaceutics  Mar 2016 
 - 979-89 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1543-8392 
<br/><br/><label>Standard No.: </label>10.1021/acs.molpharmaceut.5b00833  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Administration, Inhalation<br/>Aerosols<br/>Anti-Arrhythmia Agents--administration & dosage<br/>Antibiotics, Antitubercular--administration & dosage<br/>Cell Survival--drug effects<br/>Chemistry, Pharmaceutical<br/>Humans<br/>In Vitro Techniques<br/>Lung Neoplasms--drug therapy<br/>Microbial Sensitivity Tests<br/>Monocytes--drug effects<br/>Mycobacterium tuberculosis--drug effects<br/>Particle Size<br/>Rifampin--administration & dosage<br/>Tuberculosis--drug therapy<br/>Verapamil--administration & dosage